TransMedics (TMDX) Price to Earnings (2019 - 2026)

TransMedics has reported Price to Earnings for 8 years, with the latest figure at 156.66 in Q2 2026.

• On a quarterly basis, Price to Earnings rose 19.8% year-over-year to 156.66 in Q2 2026; TTM through Jun 2026 was 13.43, a 78.9% decrease from a year earlier, with the FY2025 full-year figure at 21.9, down 62.94% from the prior year.
• Price to Earnings was 156.66 for Q2 2026 at TransMedics, down from 471.41 in the prior quarter.
• The five-year high for Price to Earnings was 1249.8 in Q3 2024, with the low at 2733.58 in Q2 2023.
• Average Price to Earnings over 5 years is 24.61, with a median of 109.71 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Price to Earnings tumbled 3474.03% in 2023, then soared 1877.82% in 2024.
• Over 5 years, Price to Earnings stood at 284.57 in 2022, then soared by 347.32% to 703.8 in 2023, then plunged by 56.67% to 304.97 in 2024, then sank by 89.06% to 33.37 in 2025, then jumped by 369.51% to 156.66 in 2026.
• The last three Price to Earnings figures came in at 156.66 (Q2 2026), 471.41 (Q1 2026), and 33.37 (Q4 2025), per Business Quant data.